ObsEva Announces Submission of New Drug Application to U.S. FDA for Linzagolix for the Treatment of Uterine Fibroids
15 sept. 2021 01h00 HE
|
ObsEva SA
-If approved, linzagolix will be the only GnRH antagonist with flexible dose regimen options to address the clinical needs of more women with uterine fibroids- -NDA submission includes positive data...
The Marrelli Group of Companies Announces the Launch of a New Website
06 juin 2019 10h18 HE
|
The Marrelli Group of Companies
TORONTO, June 06, 2019 (GLOBE NEWSWIRE) -- The Marrelli Group of Companies (“The Marrelli Group”) is pleased to announce the launch of its newly redesigned website at...
Compliance Assurance Announces 1st-of-its-kind, Integrated GRC Management Platform for the Insurance Industry
25 sept. 2013 09h35 HE
|
Compliance Assurance Corporation
Pittsburgh, PA, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Compliance Assurance
Corporation (CAC), a leading provider of regulatory compliance
solutions, today announced the release of the first GRC...
Aveta Files Amended S-1 Registration Statement With SEC for Offering of Common Stock Issued in Private Placement
05 juin 2006 17h21 HE
|
Aveta Inc.
NEW YORK, June 5, 2006 (PRIMEZONE) -- Aveta Inc., one of the largest companies focusing on Medicare Advantage and a leader in addressing the healthcare needs of the chronically ill, announced today...
Dobson Communications To Extend Deadline on 10-K Filing
16 mars 2004 07h45 HE
|
Dobson Communications Corporation
OKLAHOMA CITY, March 16, 2004 (PRIMEZONE) -- Dobson Communications Corporation (Nasdaq:DCEL) plans to file an application with the Securities and Exchange Commission today to extend the filing period...
AdZone Research Files 10-QSB for Quarter Ended Sept. 30, 2003 and Completes Approximately $350,000 Preferred Private Placement
13 nov. 2003 16h15 HE
|
AdZone Research, Inc.
CALVERTON, N.Y., Nov. 13, 2003 (PRIMEZONE) -- AdZone Research, Inc. (OTCBB:ADZR), a pioneering Internet surveillance technology company, announced today that it has filed its Form 10-QSB for its...